These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 16228142)

  • 1. Incidence and epidemiology of heart failure.
    Kannel WB
    Heart Fail Rev; 2000 Jun; 5(2):167-73. PubMed ID: 16228142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The progression from hypertension to congestive heart failure.
    Levy D; Larson MG; Vasan RS; Kannel WB; Ho KK
    JAMA; 1996 May 22-29; 275(20):1557-62. PubMed ID: 8622246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.
    Kannel WB
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():199-212. PubMed ID: 9211012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and risk profile of cardiac failure.
    Kannel WB; Cupples A
    Cardiovasc Drugs Ther; 1988 Nov; 2 Suppl 1():387-95. PubMed ID: 3154646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need and prospects for prevention of cardiac failure.
    Kannel WB
    Eur J Clin Pharmacol; 1996; 49 Suppl 1():S3-9. PubMed ID: 8834926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
    Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Dahlöf B;
    Circulation; 2006 Jan; 113(1):67-73. PubMed ID: 16365195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and prevention of cardiac failure: Framingham Study insights.
    Kannel WB
    Eur Heart J; 1987 Sep; 8 Suppl F():23-6. PubMed ID: 3665963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
    Kannel WB; Levy D; Cupples LA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
    Haider AW; Larson MG; Franklin SS; Levy D;
    Ann Intern Med; 2003 Jan; 138(1):10-6. PubMed ID: 12513039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and risk profile of cardiac failure.
    Kannel WB; Cupples A
    Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):387-395. PubMed ID: 27722843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the epidemiology of heart failure.
    Kannel WB
    Curr Cardiol Rep; 1999 May; 1(1):11-9. PubMed ID: 10980814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of heart failure.
    Kannel WB; Belanger AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):951-7. PubMed ID: 2000773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.
    Ahmad FS; Ning H; Rich JD; Yancy CW; Lloyd-Jones DM; Wilkins JT
    JACC Heart Fail; 2016 Dec; 4(12):911-919. PubMed ID: 27908389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
    Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
    BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of asymptomatic left ventricular systolic dysfunction in the community.
    Wang TJ; Evans JC; Benjamin EJ; Levy D; LeRoy EC; Vasan RS
    Circulation; 2003 Aug; 108(8):977-82. PubMed ID: 12912813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
    Kannel WB; Wolf PA; Benjamin EJ; Levy D
    Am J Cardiol; 1998 Oct; 82(8A):2N-9N. PubMed ID: 9809895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vital epidemiologic clues in heart failure.
    Kannel WB
    J Clin Epidemiol; 2000 Mar; 53(3):229-35. PubMed ID: 10760631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of aortic root dimension in persons > or = 65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study).
    Gardin JM; Arnold AM; Polak J; Jackson S; Smith V; Gottdiener J
    Am J Cardiol; 2006 Jan; 97(2):270-5. PubMed ID: 16442377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.